Effects of self-monitoring of glucose in non-insulin treated patients with type 2 diabetes: design of the IN CONTROL-trial

被引:8
|
作者
Malanda, Uriell L. [1 ,2 ]
Bot, Sandra D. M. [1 ,2 ,3 ]
Kostense, Piet J. [1 ,3 ]
Snoek, Frank J. [1 ,4 ]
Dekker, Jacqueline M. [1 ,3 ]
Nijpels, Giel [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands
关键词
IMPROVING PRIMARY-CARE; QUALITY-OF-LIFE; BLOOD-GLUCOSE; EMOTIONAL DISTRESS; METABOLIC-CONTROL; CHRONIC ILLNESS; PROBLEM AREAS; EFFICACY; MELLITUS; QUESTIONNAIRE;
D O I
10.1186/1471-2296-10-26
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Diabetes specific emotional problems interfere with the demanding daily management of living with type 2 diabetes mellitus (T2DM). Possibly, offering direct feedback on diabetes management may diminish the presence of diabetes specific emotional problems and might enhance the patients' belief they are able to manage their illness. It is hypothesized that self-monitoring of glucose in combination with an algorithm how and when to act will motivate T2DM patients to become more active participants in their own care leading to a decrease in diabetes related distress and an increased self-efficacy. Methods and design: Six hundred patients with T2DM (45 <= 75 years) who receive care in a structured diabetes care system, HbA1c >= 7.0%, and not using insulin will be recruited and randomized into 3 groups; Self-monitoring of Blood Glucose (SMBG), Self-monitoring of Urine Glucose (SMUG) and usual care (n = 200 per group). Participants are eligible if they have a known disease duration of over 1 year and have used SMBG or SMUG less than 3 times in the previous year. All 3 groups will receive standardized diabetes care. The intervention groups will receive additional instructions on how to perform self-monitoring of glucose and how to interpret the results. Main outcome measures are changes in diabetes specific emotional distress and self-efficacy. Secondary outcome measures include difference in HbA1c, patient satisfaction, occurrence of hypoglycaemia, physical activity, costs of direct and indirect healthcare and changes in illness beliefs. Discussion: The IN CONTROL-trial is designed to explore whether feedback from self-monitoring of glucose in T2DM patients who do not require insulin can affect diabetes specific emotional distress and increase self-efficacy. Based on the self-regulation model it is hypothesized that glucose self-monitoring feedback changes illness perceptions, guiding the patient to reduce emotional responses to experienced threats, and influences the patients ability to perform and maintain self-management skills.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Effects of self-monitoring of glucose in non-insulin treated patients with type 2 diabetes: design of the IN CONTROL-trial
    Uriëll L Malanda
    Sandra DM Bot
    Piet J Kostense
    Frank J Snoek
    Jacqueline M Dekker
    Giel Nijpels
    [J]. BMC Family Practice, 10
  • [2] Blood glucose self-monitoring in diabetes control in non-insulin treated type 2 diabetic patients
    Schwedes, U
    Siebolds, M
    Mertes, G
    [J]. DIABETOLOGIA, 2001, 44 : A229 - A229
  • [3] Self-monitoring of glucose in blood or urine does not increase diabetes-specific distress in non-insulin treated patients with type 2 diabetes: results from the IN CONTROL-trial
    Malanda, U. L.
    Bot, S. D. M.
    Kostense, P. J.
    Snoek, F. J.
    Dekker, J. M.
    Nijpels, G.
    [J]. DIABETOLOGIA, 2011, 54 : S391 - S391
  • [4] The SMBG study: a randomised controlled trial of self-monitoring of blood glucose in non-insulin treated type 2 diabetes
    Parsons, S. N.
    Luzio, S. D.
    Owens, D. R.
    [J]. DIABETOLOGIA, 2017, 60 : S302 - S303
  • [5] Glucose self monitoring may not improve control in non-insulin treated type 2 diabetes
    Mayor, Susan
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [6] Examining the evidence for self-monitoring of blood glucose in non-insulin Type 2 diabetes
    Kirk, Julienne K.
    Namak, Shahla
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (01) : 1 - 4
  • [7] Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis
    Allemann, Sabin
    Houriet, Carine
    Diem, Peter
    Stettler, Christoph
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2903 - 2913
  • [8] Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial
    Sharon Parsons
    Stephen Luzio
    Stephen Bain
    John Harvey
    Jillian McKenna
    Atir Khan
    Sam Rice
    Alan Watkins
    David R. Owens
    [J]. BMC Endocrine Disorders, 17
  • [9] Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial
    Parsons, Sharon
    Luzio, Stephen
    Bain, Stephen
    Harvey, John
    McKenna, Jillian
    Khan, Atir
    Rice, Sam
    Watkins, Alan
    Owens, David R.
    [J]. BMC ENDOCRINE DISORDERS, 2017, 17
  • [10] Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial
    French, D. P.
    Wade, A. N.
    Yudkin, P.
    Neil, H. A. W.
    Kinmonth, A. L.
    Farmer, A. J.
    [J]. DIABETIC MEDICINE, 2008, 25 (10) : 1218 - 1228